1
|
Cao C, Pressman EK, Cooper EM, Guillet R, Westerman M, O'Brien KO. Placental heme receptor LRP1 correlates with the heme exporter FLVCR1 and neonatal iron status. Reproduction 2014; 148:295-302. [PMID: 24947444 DOI: 10.1530/rep-14-0053] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Abstract
LDL receptor-related protein 1 (LRP1) is a transmembrane receptor highly expressed in human placenta. It was recently found to be the receptor for heme and its plasma-binding protein hemopexin (Hx) and is integral to systemic heme clearance. Little is known about systemic concentrations of Hx during pregnancy and whether maternal Hx and placental LRP1 contributes to fetal iron (Fe) homeostasis during pregnancy. We hypothesized that placental LRP1 would be upregulated in maternal/neonatal Fe insufficiency and would be related to maternal circulating Hx. Placental LRP1 expression was assessed in 57 pregnant adolescents (14-18 years) in relationship with maternal and cord blood Fe status indicators (hemoglobin (Hb), serum ferritin, transferrin receptor), the Fe regulatory hormone hepcidin and serum Hx. Hx at mid-gestation correlated positively with Hb at mid-gestation (r=0.35, P=0.02) and Hx at delivery correlated positively with cord hepcidin (r=0.37, P=0.005). Placental LRP1 protein expression was significantly higher in women who exhibited greater decreases in serum Hx from mid-gestation to term (r=0.28, P=0.04). Significant associations were also found between placental LRP1 protein with cord hepcidin (r=-0.29, P=0.03) and placental heme exporter feline leukemia virus C receptor 1 (r=0.34, P=0.03). Our data are consistent with a role for placental heme Fe utilization in supporting fetal Fe demands.
Collapse
Affiliation(s)
- Chang Cao
- Division of Nutritional SciencesCornell University, 230 Savage Hall, Ithaca, New York 14853, USASchool of MedicineUniversity of Rochester, Rochester, New York, USAIntrinsic LifeSciencesLa Jolla, California, USA
| | - Eva K Pressman
- Division of Nutritional SciencesCornell University, 230 Savage Hall, Ithaca, New York 14853, USASchool of MedicineUniversity of Rochester, Rochester, New York, USAIntrinsic LifeSciencesLa Jolla, California, USA
| | - Elizabeth M Cooper
- Division of Nutritional SciencesCornell University, 230 Savage Hall, Ithaca, New York 14853, USASchool of MedicineUniversity of Rochester, Rochester, New York, USAIntrinsic LifeSciencesLa Jolla, California, USA
| | - Ronnie Guillet
- Division of Nutritional SciencesCornell University, 230 Savage Hall, Ithaca, New York 14853, USASchool of MedicineUniversity of Rochester, Rochester, New York, USAIntrinsic LifeSciencesLa Jolla, California, USA
| | - Mark Westerman
- Division of Nutritional SciencesCornell University, 230 Savage Hall, Ithaca, New York 14853, USASchool of MedicineUniversity of Rochester, Rochester, New York, USAIntrinsic LifeSciencesLa Jolla, California, USA
| | - Kimberly O O'Brien
- Division of Nutritional SciencesCornell University, 230 Savage Hall, Ithaca, New York 14853, USASchool of MedicineUniversity of Rochester, Rochester, New York, USAIntrinsic LifeSciencesLa Jolla, California, USA
| |
Collapse
|
2
|
Delanghe JR, Langlois MR. Hemopexin: a review of biological aspects and the role in laboratory medicine. Clin Chim Acta 2001; 312:13-23. [PMID: 11580905 DOI: 10.1016/s0009-8981(01)00586-1] [Citation(s) in RCA: 178] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
BACKGROUND Hemopexin is a heme-binding plasma glycoprotein which, after haptoglobin, forms the second line of defense against hemoglobin-mediated oxidative damage during intravascular hemolysis. A decrease in plasma hemopexin concentration reflects a recent release of heme compounds in the extracellular compartment. Heme-hemopexin complexes are delivered to hepatocytes by receptor-mediated endocytosis after which hemopexin is recycled to the circulation. METHODS OF ANALYSIS Immunonephelometric and -turbidimetric hemopexin assays are available as more precise and rapid alternatives to the radial immunodiffusion technique. INTERPRETATIONS Hemopexin determinations are not subject to interference by in vitro hemolysis. Altered serum or plasma concentrations of hemopexin are found not only in hemolytic anemias but also in other conditions such as chronic neuromuscular diseases and acute intermittent porphyria. In laboratory medicine, while hemopexin determination in tandem with haptoglobin has potential applications in the assessment of intravascular hemolysis and allows for the monitoring of the severity of hemolysis after depletion of haptoglobin, its diagnostic utility is less clear in other pathological conditions. Further studies are necessary to fully establish the clinical significance of hemopexin determination.
Collapse
Affiliation(s)
- J R Delanghe
- Department of Clinical Chemistry, Ghent University Hospital, De Pintelaan 185, B-9000, Ghent, Belgium.
| | | |
Collapse
|
4
|
Berger HM, Lindeman JH, van Zoeren-Grobben D, Houdkamp E, Schrijver J, Kanhai HH. Iron overload, free radical damage, and rhesus haemolytic disease. Lancet 1990; 335:933-6. [PMID: 1970026 DOI: 10.1016/0140-6736(90)90997-j] [Citation(s) in RCA: 39] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
To test the hypothesis that iron overload induces free radical damage in rhesus haemolytic disease (RHD), cord blood plasma of babies with RHD was compared with that of controls matched for gestational age. Babies with RHD had higher ferritin levels, lower latent iron-binding capacity, increased concentrations of lipid-peroxidation products, and low vitamin C levels. Plasma of 3 RHD babies did not inhibit peroxidation stress. These findings, of iron overload and free radical damage, have implications for treatment of RHD.
Collapse
Affiliation(s)
- H M Berger
- Department of Paediatrics, University Hospital, Leiden, The Netherlands
| | | | | | | | | | | |
Collapse
|